Specify a stock or a cryptocurrency in the search bar to get a summary
Sandoz Group AG
SDZSandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. Address: Forum 1, Basel, Switzerland, 4056
Analytics
WallStreet Target Price
31.41 CHFP/E ratio
–Dividend Yield
1.28 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SDZ
Dividend Analytics SDZ
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SDZ
Stock Valuation SDZ
Financials SDZ
Results | 2019 | Dynamics |